The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, September 10, 2019
Biohaven announced completion of enrollment in its Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally ...
read more
Monday, September 09, 2019
Janssen announced positive results from two pivotal studies to evaluate the efficacy and safety of SPRAVATO™ in addition to comprehensive SOC for ...
read more
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment...
read more
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for ...
read more
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fulvestrant ...
read more
As part of its broader efforts to reign in health care prices that place a tremendous financial burden on families throughout the state, Blue Cross ...
read more
Seqirus announced it is first-to-market with shipping its portfolio of seasonal influenza vaccines to customers in the United States for the 2019/20 ...
read more
Janssen Research & Development
Janssen Biotech has submitted a BLA to the FDA for the subcutaneous delivery of DARZALEX® (daratumumab) for patients with multiple myeloma.
read more
American Regent has announced the introduction of Selenious Acid Injection, USP.
read more
Dermata Therapeutics has announced positive results from a Phase 1 POC clinical trial of DMT410 (DMT310 + botulinum toxin (BTX)) for the treatment of ...
read more
Grifols has announced Xembify®, its new 20% subcutaneous immunoglobulin, has been approved by the FDA.
read more
The FDA is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity ...
read more
Alnylam announced new advances in its RNAi therapeutics platform, including preclinical results demonstrating oral delivery of GalNAc-conjugated small...
read more
GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline announced the FDA has approved two new methods for administering Nucala, an autoinjector and a pre-filled safety syringe.
read more
The FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
read more